Predictors of Locoregional Outcome in HER2-Overexpressing Breast Cancer Treated With Neoadjuvant Chemotherapy
D.M. Arsenault(Radiation Oncology Associates), Jean L. Wright(University of North Carolina at Chapel Hill), Judith Hurley(University of Miami), Wei Zhao(University of Miami), Isildinha M. Reis(University of Miami), Steven E. Rodgers(University of Miami), Cristiane Takita(University of Miami)
Cited by 16
Related Papers
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline
|Practical Radiation Oncology|2018|615
Effectiveness of early orthodontic treatment with the twin-block appliance: A multicenter, randomized, controlled trial. Part 1: Dental and skeletal effects
|American Journal of Orthodontics and Dentofacial Orthopedics|2003|374
Effectiveness of treatment for class II malocclusion with the herbst or twin-block appliances: a randomized, controlled trial
|American Journal of Orthodontics and Dentofacial Orthopedics|2003|275
Effectiveness of early orthodontic treatment with the twin-block appliance: a multicenter, randomized, controlled trial. Part 2: psychosocial effects
|American Journal of Orthodontics and Dentofacial Orthopedics|2003|191